We are live on ! Find out more
INZY

Inozyme Pharma

Delisted

INZY was delisted on the 30th of June, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$17.4K
Morgan Stanley
27
Morgan Stanley
New York
$13.8K -$16K -9,138 -41%
Two Sigma Investments
28
Two Sigma Investments
New York
$13K -$1.4K -800 -6%
Goldman Sachs
29
Goldman Sachs
New York
$12.5K +$20.8K +11,924 New
Bank of America
30
Bank of America
North Carolina
$7.46K +$7.3K +4,178 +143%
Barclays
31
Barclays
United Kingdom
$6.59K -$227 -130 -2%
TRCT
32
Tower Research Capital (TRC)
New York
$4K +$6.29K +3,598 New
UBS Group
33
UBS Group
Switzerland
$2.98K +$4.95K +2,834 New
Federated Hermes
34
Federated Hermes
Pennsylvania
$1.45K -$266 -152 -10%
Wells Fargo
35
Wells Fargo
California
$170 +$9 +5 +3%
DM
36
Deerfield Management
New York
-$5.6M -2,090,436 Closed
Janus Henderson Group
37
Janus Henderson Group
-$1.91M -705,577 Closed
Fidelity Investments
38
Fidelity Investments
Massachusetts
-$1.63M -609,380 Closed
Walleye Capital
39
Walleye Capital
New York
-$315K -117,529 Closed
Citadel Advisors
40
Citadel Advisors
Florida
-$297K -110,648 Closed
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
-$2K -690 Closed
Simplex Trading
42
Simplex Trading
Illinois
+$239 +137 New